Dr. Lohrey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 817-288-9700Fax+1 817-288-0070
Education & Training
- UT DallasMBA, Healthcare Administrition, 2017 - 2020
- University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 1998 - 2000
- University of Oklahoma School of Community Medicine (Tulsa)Residency, Internal Medicine/Pediatrics, 1994 - 1998
- University of Oklahoma College of MedicineClass of 1994
Certifications & Licensure
- OK State Medical License 1995 - 2025
- TX State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Publications & Presentations
PubMed
- 41 citationsPathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma.Nirmish Singla, Roy Elias, Rashed Ghandour, Yuval Freifeld, Isaac Bowman
Urologic Oncology. 2019-09-12 - 3 citationsPerioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3...Mohamad E Allaf, Se-Eun Kim, Viraj Master, David F McDermott, Lauren C Harshman
The Lancet. Oncology. 2024-08-01 - 2 citationsThe phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial.David Hsiehchen, Muhammad S Beg, Radhika Kainthla, Jay Lohrey, Syed M Kazmi
Nature Communications. 2024-03-11
Press Mentions
- Combined Therapy Makes Headway for Liver CancerMay 2nd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: